Answers are grounded in this paper and cite their sources.
Interaction of BFC1108 with Bcl-2. A, Limited proteolysis of Bcl-2 loop domain in the presence of BFC1108. Purified GST-tagged Bcl-2 loop domain and GST only control were incubated with 50 µmol/L BFC1108. The proteolysis pattern of loop domain was determined at the indicated times upon coincubation with trypsin. B, BFC1108 stabilizes and increases melting temperature (Tm) of Bcl-2 full-length protein. Thermal unfolding of Bcl-2 full-length protein in the presence of BFC1108 was monitored by SYPRO Orange fluorescence. Z-tag and no protein control samples were included to confirm BFC1108 specific interaction with Bcl-2. Two-way ANOVA with Sidak multiple comparisons post hoc test, **, P < 0.01; ****, P < 0.0001. C, BFC1108 stabilizes and increases Bcl-2 loop domain melting temperature (Tm). Thermal unfolding of Bcl-2 loop domain in the presence of BFC1108 monitored by SYPRO Orange fluorescence. One-way ANOVA with Dunnett multiple comparisons post hoc test, ****, P < 0.0001. D, MDA-MB-231/Bcl-2, H460 cells were exposed to BFC1108 at 10 µmol/L concentration for 48 hours in a medium containing 10% serum. Change in conformation of Bcl-2 was determined by using Bcl-2 BH3 antibody followed by flow cytometric analysis.
No takes yet. Share an insight, caveat, or question.
Kopparapu et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: